Oncolytic Zika Virus: New Option for Glioblastoma Treatment
DNA and Cell Biology · 01.06.2023 · 42 (6) · 267-273
DOI: 10.1089/dna.2022.0375 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift DNA and Cell Biology, erschienen am 01.06.2023. Verfasst von Chao Zhou und 3 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Pathogen and Biosecurity, Beijing Institute of Microbiology and Epidemiology, Beijing, China. Hauptthemen laut MEDLINE: Oncolytic Viruses, Glioblastoma, Zika Virus, Oncolytic Virotherapy. Die Arbeit wurde bisher 23-mal zitiert (Crossref) und nennt 79 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- State Key Laboratory of Pathogen and Biosecurity, Beijing Institute of Microbiology and Epidemiology, Beijing, China.
- Key Laboratory of Immune Microenvironment and Disease, Department of Immunology, Nanjing Medical University, Nanjing, China.
ORCID-Profile: Cheng-Feng Qin
Zitieren
APA
Zhou, C., Chen, Q., Chen, Y., & Qin, C. F. (2023). Oncolytic Zika Virus: New Option for Glioblastoma Treatment. DNA and Cell Biology, 42(6), 267-273. https://doi.org/10.1089/dna.2022.0375
Vancouver
Zhou C, Chen Q, Chen Y, Qin CF. Oncolytic Zika Virus: New Option for Glioblastoma Treatment. DNA and Cell Biology. 2023;42(6):267-273. doi:10.1089/dna.2022.0375
BibTeX
@article{Zhou2023,
author = {Zhou, Chao and Chen, Qi and Chen, Yun and Qin, Cheng-Feng},
title = {Oncolytic Zika Virus: New Option for Glioblastoma Treatment},
journal = {DNA and Cell Biology},
year = {2023},
volume = {42},
number = {6},
pages = {267--273},
doi = {10.1089/dna.2022.0375}
}
EUVIMED